Investor directory

Max Planck Society

The Max Planck Society for the Advancement of Science is a prominent non-profit research organization based in Munich, Germany. Established to promote scientific research, it operates 86 institutes and research facilities that focus on basic research across various fields, including natural sciences, life sciences, social sciences, and the arts and humanities. With a workforce of approximately 24,000, including around 15,000 scientists, the society has earned a global reputation for excellence, having been awarded more than 33 Nobel Prizes. The Max Planck Society is publicly funded by federal and state governments in Germany, and it also receives additional funding from private contributions and the European Union. Its institutes engage in interdisciplinary research and collaborate with international space agencies, developing advanced scientific instruments and conducting innovative studies to address complex scientific questions.
http://www.imprs-life.mpg.de
http://www.molgen.mpg.de
http://www.mpg.de
http://www.mpi-inf.mpg.de
http://www.mpip-mainz.mpg.de
http://www.orn.mpg.de
https://www.mps.mpg.de
https://crunchbase.com/organization/max-planck-society
https://facebook.com/mpsgoettingen
https://linkedin.com/company/max-planck-institute-for-molecular-genetics
https://twitter.com/mpi_molgen

Tobias Ritter

Director

1 past transactions

Venneos

Seed Round in 2015
Venneos GmbH, founded in 2014 in Stuttgart, Germany, is a high-tech startup that specializes in developing a silicon chip-based imaging system for the label-free analysis of biological cells. The company's flagship product, the CAN-Q, utilizes a technology known as CAN-Spectroscopy, which enables researchers to observe cellular changes, particularly in areas such as cell adhesion, that are not detectable with conventional methods. This innovative imaging system provides valuable insights for applications in tumor biology, immunology, and pharmacology, serving customers in both academia and the pharmaceutical and biotechnology sectors. As a spin-off from the Max Planck Society, Venneos aims to advance the capabilities of biological analysis through its cutting-edge technology.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.